Henning Beck-Nielsen is one of the leading experts in diabetes. He is Professor of Endocrinology at the University of Southern Denmark and Physician Consultant at Odense University Hospital.
Henning Beck-Nielsen has been specializing in diabetes for the past 30 years, and his research has mainly focused on the pathophysiology of type 2 diabetes.
Henning Beck-Nielsen obtained his medical degree in 1972 and defended his doctoral thesis in 1980 with the title “Insulin receptors in man”. He became specialist in medical endocrinology in 1985.
Henning Beck-Nielsen holds several positions of trust, among others he is head of the Danish Diabetes Academy, chairman of the board of the Danish Centre for Strategic Research in Type 2 Diabetes – DD2 and chairman of the board and founder of the company Hypo-Safe A/S. Furthermore, he was head of institute at the Institute of Clinical Research, University of Odense (1989-1998), head of the Danish Endocrine Society (1982-1986) and chairman of the Danish Medical Research Council (1998-2001).
Henning Beck-Nielsen has been official opponent of 19 dissertations (1984-2015) and assessor of 15 PhD theses (1993-2015). Furthermore, he has been supervisor of seven doctoral dissertations, 36 PhD theses and six diploma theses. He is currently supervisor for nine PhD students.
Henning Beck-Nielsen has received a number of prestigious awards and acknowledgements, among others the Order of the Dannebrog (2013), the Paul Langerhans Medal (Germany, 2013), the Bagger-Sørensen Foundation Award (2008), the Novo Nordisk Prize (2006), the Hagedorn Prize (2005) and the Kund Lundbæk Prize (Sweden, 2005).
The scientific production comprises 468 original papers in total, including 27 book chapters. ISI Web of Science indicates 673 publications, including abstracts, cited more than 16,500 times. h-index 67.